Mackay Shields LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,343
| Closed | -$10.7M | – | 609 |
|
|
2022
Q1 | $10.7M | Sell |
15,343
-458
| -3% | -$320K | 0.09% | 213 |
|
|
2021
Q4 | $9.98M | Sell |
15,801
-221
| -1% | -$140K | 0.08% | 232 |
|
|
2021
Q3 | $9.7M | Sell |
16,022
-463
| -3% | -$280K | 0.09% | 218 |
|
|
2021
Q2 | $9.21M | Sell |
16,485
-10,843
| -40% | -$6.06M | 0.09% | 224 |
|
|
2021
Q1 | $12.9M | Sell |
27,328
-20,643
| -43% | -$9.77M | 0.09% | 228 |
|
|
2020
Q4 | $23.2M | Buy |
47,971
+1,276
| +3% | +$616K | 0.16% | 143 |
|
|
2020
Q3 | $26.1M | Buy |
46,695
+2,851
| +7% | +$1.6M | 0.18% | 113 |
|
|
2020
Q2 | $27.3M | Buy |
43,844
+10,010
| +30% | +$6.24M | 0.22% | 101 |
|
|
2020
Q1 | $16.5M | Buy |
33,834
+15,164
| +81% | +$7.4M | 0.15% | 161 |
|
|
2019
Q4 | $7.01M | Sell |
18,670
-2,892
| -13% | -$1.09M | 0.05% | 399 |
|
|
2019
Q3 | $5.98M | Sell |
21,562
-6,878
| -24% | -$1.91M | 0.04% | 447 |
|
|
2019
Q2 | $8.9M | Sell |
28,440
-10,112
| -26% | -$3.16M | 0.06% | 367 |
|
|
2019
Q1 | $15.8M | Buy |
38,552
+17,480
| +83% | +$7.18M | 0.11% | 219 |
|
|
2018
Q4 | $7.87M | Buy |
21,072
+8,713
| +70% | +$3.25M | 0.06% | 361 |
|
|
2018
Q3 | $4.99M | Sell |
12,359
-160
| -1% | -$64.7K | 0.04% | 447 |
|
|
2018
Q2 | $4.32M | Sell |
12,519
-20,050
| -62% | -$6.92M | 0.03% | 518 |
|
|
2018
Q1 | $11.2M | Buy |
+32,569
| New | +$11.2M | 0.07% | 328 |
|